Skip to main content
Premium Trial:

Request an Annual Quote

Eppendorf International s DualChip Human RNAi Side Effect and BD Biosciences Clontech s BD Knockout Gene-Specific Kits


Eppendorf International last week launched its DualChip Human RNAi Side Effect array. The two-array gene chip utilizes gene expression analysis to detect side effects caused by RNAi molecules in the cell such as proliferation, differentiation, or apoptosis, the company said.

Eppendorf added that the array is suited for scientists in the fields of gene functionalization, target identification and validation, and lead optimization.

BD Biosciences Clontech has recently introduced BD Knockout Gene-Specific kits.

According to the company, the kits include ready-to-use shRNA vectors functionally proven to knock down expression of a specific gene. Each kit also includes a BD ProLabel vector construct that can be used to functionally assay for protein knockdown using a chemiluminescence assay.

Additional details about the kits can be found at


The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.